WenbinXiaoMD

PubMed

• Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in T- and/or NK-cell lymphoma patients.
  Rohan Sardana, David Nemirovsky, Denise Frosina, Achim Jungbluth, Maria E Arcila, Andriy Derkach, Ying Liu, William T Johnson, Santosha A Vardhana, Steven M Horwitz, A...> ;Blood Advances. 2024 Apr 9
• Diagnostic challenges and proposed classification of myeloid neoplasms with overlapping features of thrombocytosis, ring sideroblasts and concurrent del(5q) andmutations.
  Sarina Sherpa, Dory Londono, Xiaotian Sun, Qi Gao, Yanming Zhang, Jyoti Kumar, Natasha E Lewis, Maria E Arcila, Mikhail Roshal, Wenbin Xiao, Alexander Chan> ;Haematologica. 2024 Apr 4
• Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies.
  Krystel-Whittemore, M., Petrova-Drus, K., Ptashkin, R., Ewalt, M., Yao, J., Liu, Y., Zhu, M., Benhamida, J., Durham, B., Kumar, J., Nafa, K., Kiecka, I., Bowman, A., G...> ;Haematologica. 2024 Mar 7
• EDITION OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES.
  John K Choi, Wenbin Xiao, Xueyan Chen, Sanam Loghavi, Kojo S Elenitoba-Johnson, Kikkeri N Naresh, L Jeffrey Medeiros, Magdalena Czader> ;Modern Pathology. 2024 Mar 7
• High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer.
  Aaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, Sebastià Franch-Expósito, Ryan N Ptashkin, Swara Y Patel, Barbara Spitzer, Xiaodi Wu, Justin Jee, Pablo Sánchez...> ;Blood Advances. 2024 Feb 27
• 1 citations
  Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
  Andrew J Dunbar, Robert L Bowman, Young C Park, Kavi O'Connor, Franco Izzo, Robert M Myers, Abdul Karzai, Zach Zaroogian, Won Jun Kim, Ines Fernandez-Maestre, Michael ...> ;Cancer Discovery. 2024 Jan 12
• Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.
  Ryan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S Bowman, JinJuan Yao, Jacklyn Casanova, Yun-Te David Lin, Kseniya Petrova-Drus, Abhinita S Moh...> ;Nature Communications. 2023 Oct 28
• 6 citations
  Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia.
  Troy M Robinson, Robert L Bowman, Sonali Persaud, Ying Liu, Rosemary Neigenfind, Qi Gao, Jingping Zhang, Xiaotian Sun, Linde A Miles, Sheng F Cai, Adam Sciambi, Aaron ...> ;Science Advances. 2023 Sep 22
• Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.
  Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Dani...> ;Leukemia. 2023 Sep 1
• 3 citations
  Progression of follicular lymphoma and related entities: Report from the 2021 SH/EAHP Workshop.
  Amy S Duffield, Ahmet Dogan, Catalina Amador, James R Cook, Magdalena Czader, John R Goodlad, Reza Nejati, Wenbin Xiao, Lanie Happ, Clay Parker, Elizabeth Thacker, Dev...> ;American Journal of Clinical Pathology. 2023 May 11
• Transdifferentiation, phenotypic infidelity, progression, and transformation in T/NK-cell neoplasms: Report from the 2021 SH/EAHP Workshop.
  Catalina Amador, James R Cook, Magdalena Czader, Amy Duffield, John Goodlad, Reza Nejati, German Ott, Wenbin Xiao, Sandeep Dave, Mariusz A Wasik, Ahmet Dogan> ;American Journal of Clinical Pathology. 2023 May 11
• Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia.
  Evan Atchley, Taylor M Weis, Andriy Derkach, Pallavi K Galera, Wenbin Xiao, Jacob Glass, Susan DeWolf, Mikhail Roshal, Richa Shah, Sarah E Stump> ;Leukemia Research. 2023 Jul 1
• 5 citations
  Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.
  Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty, Zoe S Stone-Molloy, Jordan Chervin, Brian J Ball, Zachary D Epstein...> ;Blood Advances. 2023 Sep 12
• 1 citations
  Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP Workshop.
  James R Cook, Catalina Amador, Magdalena Czader, Amy Duffield, John Goodlad, German Ott, Wenbin Xiao, Sandeep Dave, Devang Thakkar, Elizabeth Thacker, Ahmet Dogan, Mar...> ;American Journal of Clinical Pathology. 2023 Apr 26
• Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop.
  Reza Nejati, Catalina Amador, Magdalena Czader, Elizabeth Thacker, Devang Thakkar, Sandeep S Dave, Ahmet Dogan, Amy Duffield, John R Goodlad, German Ott, Mariusz A Was...> ;American Journal of Clinical Pathology. 2023 Jun 1
• 1 citations
  Phenotypic and genotypic infidelity in B-lineage neoplasms, including transdifferentiation following targeted therapy: Report from the 2021 SH/EAHP Workshop.
  John R Goodlad, Wenbin Xiao, Catalina Amador, James R Cook, Lanie Happ, Devang Thakkar, Sandeep Dave, Ahmet Dogan, Amy Duffield, Reza Nejati, German Ott, Mariusz Wasik...> ;American Journal of Clinical Pathology. 2023 Jun 1
• Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop.
  Magdalena Czader, Catalina Amador, James R Cook, Devang Thakkar, Clay Parker, Sandeep S Dave, Ahmet Dogan, Amy S Duffield, Reza Nejati, German Ott, Wenbin Xiao, Marius...> ;American Journal of Clinical Pathology. 2023 Jun 1
• 2 citations
  B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report f...
  Wenbin Xiao, Catalina Amador, James R Cook, Magdalena Czader, Sandeep Dave, Ahmet Dogan, Amy Duffield, John Goodlad, Reza Nejati, German Ott, Mariusz Wasik> ;American Journal of Clinical Pathology. 2023 Jun 1
• Primary thymic marginal zone lymphoma with amyloidosis.
  Krasimira A Rozenova, Wenbin Xiao> ;Blood. 2023 Mar 23
• 1 citations
  Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
  Ling Zhang, Bijal Shah, Yumeng Zhang, Hammad Tashkandi, Wenbin Xiao, Sebastian Fernandez-Pol, Maria Vergara-Lluri, Mohammad Hussaini, Jinming Song, Jeffrey Lancet, Lyn...> ;Human Pathology. 2023 Jun 1
• 3 citations
  Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal.
  Mark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, Alice S Mims, Victoria Klein, Deepika Dilip, Jacob L Glass, Gerard Lozanski, Hani Hassoun, Heather Landau, Yanming Zh...> ;Blood Advances. 2023 Jul 11
• 6 citations
  CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis.
  Andrew J Dunbar, Dongjoo Kim, Min Lu, Mirko Farina, Robert L Bowman, Julie L Yang, Young Park, Abdul Karzai, Wenbin Xiao, Zach Zaroogian, Kavi O'Connor, Shoron Mowla, ...> ;Blood. 2023 May 18
• 1 citations
  Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm.
  Ying Liu, Andriy Derkach, Natasha Lewis, Menglei Zhu, Yanming Zhang, Maria Arcila, Gilles Salles, Ahmet Dogan, Wenbin Xiao> ;Haematologica. 2023 Mar 1
• 2 citations
  Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
  Maximilian Stahl, Andriy Derkach, Noushin Farnoud, Jan Philipp Bewersdorf, Troy Robinson, Christopher Famulare, Christina Cho, Sean Devlin, Kamal Menghrajani, Minal A ...> ;American Journal of Hematology. 2023 Jan 1
• 988 citations
  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
  Khoury, J., Solary, E., Abla, O., Akkari, Y., Alaggio, R., Apperley, J., Bejar, R., Berti, E., Busque, L., Chan, J., Chen, W., Chen, X., Chng, W., Choi, J., Colmenero,...> ;Leukemia. 2022 Jul 1
• Join now to see all

Abstracts/Posters

• A Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL / SLLA Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or R...
  Jennifer R Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Stag2 Regulates Hematopoietic Differentiation and Self-Renewal through Alterations in Gene Expression and Topological Control
  Wenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents
  Jennifer R Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute Leukemia
  Wenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• High Surface Expression of CD49d (VLA-4) and CD79b Correlates with Acalabrutinib Resistance in Patients with Chronic Lymphocytic Leukemia (CLL)
  Jennifer R Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase
  Wenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Incidence of Germline ATM Variants in a Consecutive Clinical Cohort of CLL Patients
  Jennifer R Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Aberrant SYK Expression As a Potential Therapeutic Target in T/NK Cell Neoplasms
  Wenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL / SLLA Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or R...
  Jennifer R Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018